MedTrace Logo

Muscle Selection for Botulinum Toxin A Injection in Poststroke Elbow Flexor Spasticity

NCT04036981 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 55

Last updated 2021-06-23

No results posted yet for this study

Summary

Botulinum toxin A (BoNT A) has been reported to be effective in the treatment of elbow flexor spasticity. Although BoNT A is an efficacious treatment option, there is a debate in the selection of target muscle(s) for BoNT injection in the treatment of poststroke elbow flexor spasticity. The decision of muscle selection for BoNT A injection is mostly made according to the physical examination findings in real life practice.One of the guiding findings in this decision is the position of the spastic arm.

In this study, hypothesis is that the change in severity of spasticity with BoNT A injection differs depending on the muscle selection in chronic stroke patients with elbow flexor and forearm pronator spasticity.

Conditions

  • Muscle Spasticity

Interventions

DRUG

Botulinum toxin type A

Injection of botulinum toxin A into the spastic elbow flexor muscle or muscles

Sponsors & Collaborators

  • Izmir Katip Celebi University

    lead OTHER

Principal Investigators

  • İlker Şengül, M.D. · Izmir Katip Celebi University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-10
Primary Completion
2021-05-03
Completion
2021-06-01
FDA Drug
Yes

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04036981 on ClinicalTrials.gov